Resilience against AD neuropathology might rely on the amyloid plaque microenvironment. Want to learn more? Check out our paper in Acta Neuropathologica! Excellent job @NurJury @pbmartinc @EChimalJ in the lab and our collabs @jungsukim77 @HandeKarahan_

Our first department newsletter is here! 📰 Featuring news, research, clinical highlights, and outreach updates — a snapshot of the incredible work across our team. 👉 Read the full issue: https://t.co/L9WGJDADDU #NewsletterLaunch #DepartmentNews #AcademicMedicine

The Dementia Prevention and Research Institute of Texas, approved by two-thirds of voters in a 4 November ballot measure, authorizes $3 billion in state surplus funds to be awarded over 10 years to Texas-based researchers for work in Alzheimer’s, Parkinson’s, and other diseases.

WE DID IT! 🎊 Voters across Texas made their voices heard at the ballot box and passed Proposition 14, authorizing a $3 billion investment to fund DPRIT. The Lone Star State will be home to the largest state-funded dementia research program in the U.S.

Congratulations @PatelHenika for your award at the #Alzheimer’s & #Dementia Research Symposium of Southeast Texas @alztex and for representing the @LasagnaLab!! @bcmhouston @BCMFromtheLabs @bcmneurology

Innovation in brain science starts with investment. Support dementia research and a healthier future for Texans. 🧠 🗳️ Early voting through Oct. 31. Vote YES on Prop 14 — Nov. 4. #BrainHealth #Neurology #Prop14

¡Política sanitaria que salva vidas! Revista @TheLancetInfDis destaca a nuestro país por la aplicación del anticuerpo monoclonal contra el Virus Respiratorio Sincicial. Esta política pública ha significado que en Chile por dos años consecutivos (2024-2025) -en el marco de la

Our president & CEO @joannepikedrph urges her fellow Texans to #VoteYesOnAlz14 🗳️ to fund the Dementia Prevention Research Institute of Texas (DPRIT) — creating the largest state-funded Alzheimer’s research program in the country. Read her @dallasnews op-ed to learn more about

On the Texas ballot this fall is Proposition 14, which would create the Dementia Prevention and Research Institute of Texas (DPRIT), a $3 billion, 10-year investment in research, prevention and innovation related to neurodegenerative diseases. Learn More: https://t.co/mVzrEqBMGH

Research from Dr. Cristian Lasagna-Reeves (@LasagnaLab), a 2024 #RainwaterPrize winner, provides the first in vivo evidence of the beneficial effects of tau downregulation in a CAA mouse model. Read more about past Rainwater Prize winners: https://t.co/TkJ7PAXseZ

We are excited to announce a new open search for a tenure track Assistant Professor position within the Brown University Center for Alzheimer's Disease Research! Apply here:

The 2025 Tau Consortium™ Investigators Meeting gathered experts across disciplines to accelerate the search for treatments for primary tauopathies. Learn more about this dynamic annual meeting and the Tau Consortium’s newly adopted 5-year goals.

Texans, today is the last day to register to vote! We need your voice to help make history on November 4 when we pass Proposition 14, which will create the largest state-funded dementia research program in the country. #YesOnAlz14

Las tendencias en cobertura de vacunación para niños < 1 año en América Latina no son buenas. Solo Chile logrará cobertura del 98.89% para el 2030. #19VaccineCongress

The Texas legislature recently established the Dementia Prevention and Research Institute of Texas (DPRIT). It’s up to us to fund it. I’m proud to stand with the @alzassociation in support of #VotesYesOnAlz14 to accelerate dementia research. Join us:

Grateful to @DrMariaALZ and @HeatherAlz from @alzassociation for supporting Alzheimer’s research in Latin America, to @hsalvadorcl, @ministeriosalud and @uchile for enabling research embedded in care, and @GBHI_Fellows for all its support

🎉 Huge congrats to @LasagnaLab, named an Emerging Leader in Health & Medicine by @theNAMedicine! #Innovation #HealthLeadership

🧠 Big news: The U.S. POINTER study found that lifestyle changes can improve cognition in older adults at risk for decline. Baylor College of Medicine was proud to be a trial site! 🗞️: https://t.co/WCc5d4bgw8 #BrainHealth #Alzheimers #USPOINTER #CognitiveDecline #HealthyAging

Join us in congratulating @UFCTRND/@UFNeuroscience faculty Dr. Jose Abisambra on his recent promotion to Professor in the UF Department of Neuroscience. His lab uses animal and cell culture models to examine the pathogenesis of Alzheimer’s disease, FTD, CTE, and more.

For the seventh consecutive year, the team at #BCMNeurosurgery, @bcmneurology and @StLukesHealthTX has been named as one of the top programs in the country for neurological and neurosurgical care! 🧠 We're extremely proud of and grateful for this #neuro team! 👏

Fellow Texans: we have an opportunity to change the course of dementia research in our state. On Nov. 4, #VoteYesOnAlz14 to ensure Texas allocates $3 billion over 10 years for dementia research in the Lone Star State. See below for more information.